{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:11:07Z","timestamp":1773090667082,"version":"3.50.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Evaluating barriers that may delay or limit human growth hormone (hGH) access is important to ensure timely and equitable treatment. We examined time to hGH access and whether time to approval was associated with patient factors and impacts on patient growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a single-center, retrospective review of the electronic medical records of pediatric patients starting hGH treatment for an indication approved by the FDA at the Vanderbilt Pediatric Endocrinology Clinic between January 1, 2018, and December 31, 2020. A Cox proportional hazards model was used to assess factors associated with time to access. Linear regression analysis was used to assess factors impacting patients\u2019 change in height z score from baseline to 1 year after the decision to treat (DTT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The inclusion criteria were met by 374 patients. Patients had a median age of 11 years (interquartile range [IQR], 8-13 years), 66% were male, 80% identified as White, and the median pretreatment height z score was \u20132.5 (IQR, \u20133 to \u20132). The median time to access was 3 days (IQR, 1-6 days) with a prior authorization, 34 days (IQR, 22-68 days) with an appeal, 84 days (IQR, 59-122 days) with a patient assistance program, and 94 days (IQR, 46-155 days) with cash pay. Diagnosis (P = 0.002), additional testing (P &amp;lt; 0.0001), and method of final access (P &amp;lt; 0.001) were significantly associated with the time to access. Height z score at DTT (P &amp;lt; 0.001), diagnosis (P = 0.021), and race (P = 0.045) were significantly associated with the change in height at 1 year after DTT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Diagnosis, insurance, additional testing, and method of medication approval were associated with time to access. Time to hGH initiation did not impact patient growth 1 year after DTT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaf232","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T08:51:34Z","timestamp":1756803094000},"page":"272-280","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to growth hormone access in pediatric patients at an academic medical center"],"prefix":"10.1093","volume":"83","author":[{"given":"Chard\u00e9","family":"Parrish","sequence":"first","affiliation":[{"name":"Vanderbilt Specialty Pharmacy, Vanderbilt Health System , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Baird","sequence":"additional","affiliation":[{"name":"Vanderbilt Specialty Pharmacy, Vanderbilt Health System , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terra","family":"Redd","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Lipscomb University , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan P","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-7090","authenticated-orcid":false,"given":"Leena","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn D","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Vanderbilt Specialty Pharmacy, Vanderbilt Health System , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie R","family":"Cruchelow","sequence":"additional","affiliation":[{"name":"Vanderbilt Specialty Pharmacy, Vanderbilt Health System , Nashville, TN ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"4","key":"2026030907331066200_zxaf232-B1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/mop.0000000000000505","article-title":"Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence","volume":"29","author":"Grimberg","year":"2017","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"2026030907331066200_zxaf232-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06715-8","article-title":"Human growth hormone","volume":"46","author":"Strobl","year":"1994","journal-title":"Pharmacol Rev"},{"issue":"6","key":"2026030907331066200_zxaf232-B3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1517\/14712598.2013.795941","article-title":"Growth hormone therapy with Norditropin (somatropin) in growth hormone deficiency","volume":"13","author":"Pawlikowska-Haddal","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"s337","key":"2026030907331066200_zxaf232-B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1651-2227.1987.tb17121.x","article-title":"Early initiation of growth hormone treatment: influence on final height","volume":"76","author":"Vanderschueren-Lodeweyckx","year":"1987","journal-title":"Acta Paediatr"},{"issue":"18","key":"2026030907331066200_zxaf232-B5","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/jama.2021.17764","article-title":"A policy prescription for reducing health disparities\u2014achieving pharmacoequity","volume":"326","author":"Essien","year":"2021","journal-title":"JAMA"},{"key":"2026030907331066200_zxaf232-B6","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"2026030907331066200_zxaf232-B7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2026030907331066200_zxaf232-B8","author":"R Core Team","year":"2020"},{"issue":"21","key":"2026030907331066200_zxaf232-B9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/ajhp\/zxac212","article-title":"Health-system specialty pharmacy role and outcomes: a review of current literature","volume":"79","author":"Zuckerman","year":"2022","journal-title":"Am J Health-Syst Pharm"},{"issue":"3","key":"2026030907331066200_zxaf232-B10","doi-asserted-by":"publisher","first-page":"Cd004440","DOI":"10.1002\/14651858.CD004440.pub2","article-title":"Recombinant growth hormone for idiopathic short stature in children and adolescents","author":"Bryant","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2026030907331066200_zxaf232-B11","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1345\/aph.1D548","article-title":"Growth hormone use in children with idiopathic short stature","volume":"38","author":"Weise","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2026030907331066200_zxaf232-B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13633-020-00090-6","article-title":"Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program and NordiNet international outcome study","volume":"2020","author":"Angulo","year":"2020","journal-title":"Int J Pediatr Endocrinol"},{"key":"2026030907331066200_zxaf232-B13","doi-asserted-by":"publisher","first-page":"c7157","DOI":"10.1136\/bmj.c7157","article-title":"Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review","volume":"342","author":"Deodati","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"2026030907331066200_zxaf232-B14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/s0022-3476(05)80647-x","article-title":"Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children","volume":"116","author":"August","year":"1990","journal-title":"J Pediatr"},{"key":"2026030907331066200_zxaf232-B15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jpeds.2021.04.034","article-title":"Racial and ethnic disparities in the investigation and treatment of growth hormone deficiency","volume":"236","author":"Hawkes","year":"2021","journal-title":"J Pediatr"},{"key":"2026030907331066200_zxaf232-B16","doi-asserted-by":"publisher","first-page":"989404","DOI":"10.3389\/fendo.2022.989404","article-title":"Identifying and addressing disparities in the evaluation and treatment of children with growth hormone deficiency","volume":"13","author":"Beliard","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026030907331066200_zxaf232-B17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000491793","article-title":"Racial\/ethnic disparities in US pediatric growth hormone treatment","volume":"90","author":"Grimberg","year":"2018","journal-title":"Horm Res Paediatr"},{"issue":"suppl 2","key":"2026030907331066200_zxaf232-B18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.17458\/per.vol14.2017.lm.childrenshortstature","article-title":"Children with short stature and growth failure: heightism, gender and racial disparities","volume":"14","author":"Lipman","year":"2017","journal-title":"Pediatr Endocrinol Rev"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxaf232\/64189039\/zxaf232.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/6\/272\/64189039\/zxaf232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/6\/272\/64189039\/zxaf232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:33:17Z","timestamp":1773055997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/6\/272\/8245654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,2]]},"published-print":{"date-parts":[[2026,3,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaf232","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2025,9,2]]}}}